Moss Adams Wealth Advisors LLC Avidity Biosciences, Inc. Transaction History
Moss Adams Wealth Advisors LLC
- $913 Billion
- Q3 2024
A detailed history of Moss Adams Wealth Advisors LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Moss Adams Wealth Advisors LLC holds 22,496 shares of RNA stock, worth $656,433. This represents 0.11% of its overall portfolio holdings.
Number of Shares
22,496
Previous 38,213
41.13%
Holding current value
$656,433
Previous $1.56 Billion
33.81%
% of portfolio
0.11%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding RNA
# of Institutions
255Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$310 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$269 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$252 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$237 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$205 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.52B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...